Cost-effectiveness analysis of human papillomavirus-vaccination programs to prevent cervical cancer in Austria (Q84147489)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19567244%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Cost-effectiveness analysis of human papillomavirus-vaccination programs to prevent cervical cancer in Austria (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19567244%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

main subject

Austria

0 references

cervix uterine cancer

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19567244%20AND%20SRC:MED&resulttype=core&format=json

Birgitte Freiesleben de Blasio

1 February 2020

2

object named as

Birgitte Freiesleben de Blasio

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19567244%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Ingrid Zechmeister

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19567244%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Geoff Garnett

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19567244%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Aileen Rae Neilson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19567244%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

28 June 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19567244%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19567244%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19567244%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19567244%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

5133-5141

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19567244%20AND%20SRC:MED&resulttype=core&format=json

Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.039

Potential health and economic impact of adding a human papillomavirus vaccine to screening programs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.039

Health and economic implications of HPV vaccination in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.039

Cost-effectiveness of HPV 16, 18 vaccination in Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.039

Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.039

Cost-effectiveness of quadrivalent human papillomavirus (HPV) vaccination in Mexico: a transmission dynamic model-based evaluation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.039

Economic evaluation of human papillomavirus vaccination in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.039

The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.039

Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.039

Cost-effectiveness of a potential vaccine for human papillomavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.039

Evaluating human papillomavirus vaccination programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.039

Model for assessing human papillomavirus vaccination strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.039

Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.039

A decision chart for assessing and improving the transferability of economic evaluation results between countries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.039

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.039

Detection of HPV in Norwegian cervical biopsy specimens with type-specific PCR and reverse line blot assays.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.039

Multiparameter Calibration of a Natural History Model of Cervical Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.039

Natural history of cervicovaginal papillomavirus infection in young women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.039

Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.039

Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.039

10.1016/J.VACCINE.2009.06.039

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19567244%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference